Kissei Pharmaceutical Co., Ltd.
General ticker "KSPHF" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $1.1B (TTM average)
Kissei Pharmaceutical Co., Ltd. follows the US Stock Market performance with the rate: 12.0%.
Estimated limits based on current volatility of 0.0%: low 25.77$, high 25.77$
Factors to consider:
- Earnings expected soon, date: nan
- Company pays dividends (annually): last record date 2026-03-31, amount 40.42$ (Y156.85%)
Short-term KSPHF quotes
Long-term KSPHF plot
Financial data
| YTD | 2024-03-31 | 2025-03-31 |
|---|---|---|
| Operating Revenue | ¥75,579.00MM | ¥88,330.00MM |
| Operating Expenses | ¥71,562.00MM | ¥82,557.00MM |
| Operating Income | ¥4,017.00MM | ¥5,773.00MM |
| Non-Operating Income | ¥10,432.00MM | ¥9,837.00MM |
| Interest Expense | ¥18.00MM | ¥21.00MM |
| Income(Loss) | ¥14,449.00MM | ¥15,610.00MM |
| Taxes | ¥3,159.00MM | ¥3,634.00MM |
| Profit(Loss)* | ¥11,160.00MM | ¥11,961.00MM |
| Stockholders Equity | ¥220,029.00MM | ¥209,003.00MM |
| Assets | ¥260,929.00MM | ¥244,059.00MM |
| Operating Cash Flow | ¥-1,677.00MM | ¥6,521.00MM |
| Capital expenditure | ¥1,833.00MM | ¥5,030.00MM |
| Investing Cash Flow | ¥8,690.00MM | ¥4,952.00MM |
| Financing Cash Flow | ¥-10,006.00MM | ¥-9,325.00MM |
| Earnings Per Share** | ¥246.59 | ¥274.21 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.